Patents by Inventor Immaculada Ros

Immaculada Ros has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060258849
    Abstract: The invention provides proteins from group B streptococcus (Streptococcus agalactiae) and group A streptococcus (Streptococcus pyogenes), including amino acid sequences and the corresponding nucleotide sequences. Data are given to show that the proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics. The proteins are also targets for antibiotics.
    Type: Application
    Filed: May 16, 2006
    Publication date: November 16, 2006
    Applicant: Novartis Vaccines and Diagnostics, Inc.
    Inventors: John Telford, Vega Masignani, Immaculada Ros, Guido Grandi, Claire Fraser, Herve Tettelin
  • Publication number: 20060210579
    Abstract: The invention provides proteins from group B streptococcus (Streptococcus agalactiae) and group A streptococcus (Streptococcus pyogenes), including amino acid sequences and the corresponding nucleotide sequences. Data are given to show that the proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics. The proteins are also targets for antibiotics.
    Type: Application
    Filed: May 16, 2006
    Publication date: September 21, 2006
    Applicant: Novartis Vaccines and Diagnostics, Inc.
    Inventors: John Telford, Vega Masignani, Immaculada Ros, Guido Grandi, Claire Fraser, Herve Tettelin
  • Publication number: 20060210581
    Abstract: The invention provides proteins from group B streptococcus (Streptococcus agalactiae) and group A streptococcus (Streptococcus pyogenes), including amino acid sequences and the corresponding nucleotide sequences. Data are given to show that the proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics. The proteins are also targets for antibiotics.
    Type: Application
    Filed: May 16, 2006
    Publication date: September 21, 2006
    Applicant: Novartis Vaccines and Diagnostics, Inc.
    Inventors: John Telford, Vega Masignani, Immaculada Ros, Guido Grandi, Claire Fraser, Herve Tettelin
  • Publication number: 20060210582
    Abstract: The invention provides proteins from group B streptococcus (Streptococcus agalactiae) and group A streptococcus (Streptococcus pyogenes), including amino acid sequences and the corresponding nucleotide sequences. Data are given to show that the proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics. The proteins are also targets for antibiotics.
    Type: Application
    Filed: May 16, 2006
    Publication date: September 21, 2006
    Applicant: Novartis Vaccines and Diagnostics, Inc.
    Inventors: John Telford, Vega Masignani, Immaculada Ros, Guido Grandi, Claire Fraser, Herve Tettelin
  • Publication number: 20060210580
    Abstract: The invention provides proteins from group B streptococcus (Streptococcus agalactiae) and group A streptococcus (Streptococcus pyogenes), including amino acid sequences and the corresponding nucleotide sequences. Data are given to show that the proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics. The proteins are also targets for antibiotics.
    Type: Application
    Filed: May 16, 2006
    Publication date: September 21, 2006
    Applicant: Novartis Vaccines and Diagnostics, Inc.
    Inventors: John Telford, Vega Masignani, Immaculada Ros, Guido Grandi, Claire Fraser, Herve Tettelin